Showing results (301-310 of 681) with videos related to
Sort By:
Pageof 69
Current Molecular Pharmacology|December 22, 2009
G protein--mediated signaling: same receptor, multiple effectorsAndrew Woehler, Evgeni G PonimaskinCurrent Molecular Pharmacology|December 25, 2009
EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistanceHui-Wen LoCurrent Molecular Pharmacology|October 16, 2018
Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?Alexander V Zholos, Olesia F Moroz, Maksim V StorozhukCurrent Molecular Pharmacology|October 14, 2021
Pharmacotherapy for SARS-CoV-2 and Seizures for Drug Repurposing Presumed on Mechanistic TargetsDivya Goel, Ankit Srivastava, Ángel Aledo-Serrano, et al.Current Molecular Pharmacology|October 15, 2021
Immunopharmacological Properties of VitD3: 1, 25VitD3 Modulates Regulatory T Cells and Th17 Cells and the Cytokine Balance in PBMCs from Women with Unexplained Recurrent Spontaneous Abortion (URSA)Jiefan Gao, Li Wang, Lei Bu, et al.Current Molecular Pharmacology|August 26, 2020
A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine DrugKrishna P Naduchamy, Varadarajan ParthasarathyCurrent Molecular Pharmacology|March 31, 2023
IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma GrowthTiesuo Zhao, Mengmeng Guo, Haoqi Chen, et al.Current Molecular Pharmacology|March 31, 2023
Antimicrobial Resistance of Clinical Klebsiella pneumoniae Isolates: Involvement of AcrAB and OqxAB Efflux PumpsOsman Albarri, Manaf AlMatar, Işil Var, et al.Current Molecular Pharmacology|June 10, 2025
Corrigendum to: Bedaquiline in Drug-Resistant Tuberculosis: A Mini-ReviewBaljinder Singh, Charan SinghCurrent Molecular Pharmacology|February 19, 2024
A Review of the Dual Role of MicroRNA-21 in Cardiovascular Diseases: Risk Factor or a Potential Therapeutic TargetAmir Masoud Jafari-Nozad, Negin Rostami, Melika Esmaeili, et al.Pageof 69